Learn More
Medchemexpress LLC Eb-42486 | 2390475-81-5 | 99.6% | 414.46 g·mol⁻¹ | C22H22N8O | 5 MG

Supplier: Medchemexpress LLC HY1426475MG
EB-42486 is a small-molecule inhibitor selective for the G2019S mutant of LRRK2. It displays sub-nanomolar inhibitory potency and is supplied as a high-purity solid for preclinical research applications, including studies of Parkinson's disease-related pathways.
- Highly selective for the G2019S LRRK2 mutant.
- Sub-nanomolar potency (IC50 < 0.2 nM).
- High purity (99.6%).
- Molecular weight 414.46 g·mol⁻¹; formula C22H22N8O.
- Solid, off-white to light yellow appearance.
- Storage: powder -20°C for 3 years or 4°C for 2 years; in solvent -80°C for 6 months.
- Intended for preclinical research in Parkinson's disease models.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.